Suppr超能文献

蛋白激酶抑制剂数据库:蛋白激酶 P 环的结构变异性和抑制剂相互作用。

Protein kinase-inhibitor database: structural variability of and inhibitor interactions with the protein kinase P-loop.

机构信息

Department of Medicinal Chemistry, School of Pharmacy, University of Mississippi, University, Mississippi 38677-1848, USA.

出版信息

J Proteome Res. 2010 Sep 3;9(9):4433-42. doi: 10.1021/pr100662s.

Abstract

Structure-based drug design of protein-kinase inhibitors has been facilitated by availability of an enormous number of structures in the Protein Databank (PDB), systematic analyses of which can provide insight into the factors that govern ligand-protein kinase interactions and into the conformational variability of the protein kinases. In this study, a nonredundant database containing 755 unique, curated, and annotated PDB protein kinase-inhibitor complexes (each consisting of a single protein kinase chain, a ligand, and water molecules around the ligand) was created. With this dataset, analyses were performed of protein conformational variability and interactions of ligands with 11 P-loop residues. Analysis of ligand-protein interactions included ligand atom preference, ligand-protein hydrogen bonds, and the number and position of crystallographic water molecules around important P-loop residues. Analysis of variability in the conformation of the P-loop considered backbone and side-chain dihedral angles, and solvent accessible surface area (SASA). A distorted conformation of the P-loop was observed for some of the protein kinase structures. Lower SASA was observed for the hydrophobic residue in beta1 of several members of the AGC family of protein kinases. Our systematic studies were performed amino acid-by-amino acid, which is unusual for analyses of protein kinase-inhibitor complexes.

摘要

基于结构的蛋白激酶抑制剂药物设计得益于蛋白质数据库(PDB)中大量结构的可用性,对这些结构的系统分析可以深入了解控制配体-蛋白激酶相互作用的因素,以及蛋白激酶的构象可变性。在这项研究中,创建了一个包含 755 个独特、经过精心筛选和注释的 PDB 蛋白激酶-抑制剂复合物的非冗余数据库(每个复合物由单个蛋白激酶链、配体和配体周围的水分子组成)。利用该数据集,对 11 个 P 环残基的蛋白构象变异性和配体相互作用进行了分析。配体-蛋白相互作用分析包括配体原子偏好、配体-蛋白氢键以及围绕重要 P 环残基的结晶水分子数量和位置。对 P 环构象变异性的分析考虑了骨架和侧链二面角以及溶剂可及表面积(SASA)。对于一些蛋白激酶结构,观察到 P 环的构象扭曲。在 AGC 家族的几种蛋白激酶中,β1 位的疏水残基的 SASA 较低。我们的系统研究是逐个氨基酸进行的,这对于蛋白激酶-抑制剂复合物的分析来说是不寻常的。

相似文献

2
KLIFS: a knowledge-based structural database to navigate kinase-ligand interaction space.
J Med Chem. 2014 Jan 23;57(2):249-77. doi: 10.1021/jm400378w. Epub 2013 Sep 20.
3
A comprehensive exploration of the druggable conformational space of protein kinases using AI-predicted structures.
PLoS Comput Biol. 2024 Jul 24;20(7):e1012302. doi: 10.1371/journal.pcbi.1012302. eCollection 2024 Jul.
4
Kincore: a web resource for structural classification of protein kinases and their inhibitors.
Nucleic Acids Res. 2022 Jan 7;50(D1):D654-D664. doi: 10.1093/nar/gkab920.
5
Evolutionary variation and adaptation in a conserved protein kinase allosteric network: implications for inhibitor design.
Biochim Biophys Acta. 2013 Jul;1834(7):1322-9. doi: 10.1016/j.bbapap.2013.02.040. Epub 2013 Mar 14.
6
Strong and weak hydrogen bonds in protein-ligand complexes of kinases: a comparative study.
Amino Acids. 2008 May;34(4):617-33. doi: 10.1007/s00726-007-0015-4. Epub 2008 Jan 8.
8
Kinase hinge binding scaffolds and their hydrogen bond patterns.
Bioorg Med Chem. 2015 Oct 1;23(19):6520-7. doi: 10.1016/j.bmc.2015.08.006. Epub 2015 Aug 29.
9
10
Transplant-insert-constrain-relax-assemble (TICRA): protein-ligand complex structure modeling and application to kinases.
J Chem Inf Model. 2011 Jan 24;51(1):52-60. doi: 10.1021/ci100256u. Epub 2010 Nov 30.

引用本文的文献

1
The prospect of substrate-based kinase inhibitors to improve target selectivity and overcome drug resistance.
Chem Sci. 2024 Jul 13;15(33):13130-13147. doi: 10.1039/d4sc01088d. eCollection 2024 Aug 22.
2
Validation of an Allosteric Binding Site of Src Kinase Identified by Unbiased Ligand Binding Simulations.
J Mol Biol. 2022 Sep 15;434(17):167628. doi: 10.1016/j.jmb.2022.167628. Epub 2022 May 17.
3
Structural Basis for Targeting the Folded P-Loop Conformation of c-MET.
ACS Med Chem Lett. 2020 Dec 8;12(1):162-167. doi: 10.1021/acsmedchemlett.0c00392. eCollection 2021 Jan 14.
4
Encounter complexes and hidden poses of kinase-inhibitor binding on the free-energy landscape.
Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18404-18409. doi: 10.1073/pnas.1904707116. Epub 2019 Aug 26.
5
Systematic Studies on the Protocol and Criteria for Selecting a Covalent Docking Tool.
Molecules. 2019 Jun 10;24(11):2183. doi: 10.3390/molecules24112183.
6
Computational analysis of kinase inhibitor selectivity using structural knowledge.
Bioinformatics. 2019 Jan 15;35(2):235-242. doi: 10.1093/bioinformatics/bty582.
7
Kinase-targeted cancer therapies: progress, challenges and future directions.
Mol Cancer. 2018 Feb 19;17(1):48. doi: 10.1186/s12943-018-0804-2.
8
Determining Cysteines Available for Covalent Inhibition Across the Human Kinome.
J Med Chem. 2017 Apr 13;60(7):2879-2889. doi: 10.1021/acs.jmedchem.6b01815. Epub 2017 Apr 4.
9
Optimal strategies for virtual screening of induced-fit and flexible target in the 2015 D3R Grand Challenge.
J Comput Aided Mol Des. 2016 Sep;30(9):695-706. doi: 10.1007/s10822-016-9941-0. Epub 2016 Aug 29.

本文引用的文献

2
Insights into protein kinase regulation and inhibition by large scale structural comparison.
Biochim Biophys Acta. 2010 Mar;1804(3):429-32. doi: 10.1016/j.bbapap.2009.10.013. Epub 2009 Oct 22.
3
Binding site similarity analysis for the functional classification of the protein kinase family.
J Chem Inf Model. 2009 Feb;49(2):318-29. doi: 10.1021/ci800289y.
4
First inactive conformation of CK2 alpha, the catalytic subunit of protein kinase CK2.
J Mol Biol. 2009 Mar 13;386(5):1212-21. doi: 10.1016/j.jmb.2009.01.033. Epub 2009 Jan 24.
6
The Universal Protein Resource (UniProt) 2009.
Nucleic Acids Res. 2009 Jan;37(Database issue):D169-74. doi: 10.1093/nar/gkn664. Epub 2008 Oct 4.
7
A helix scaffold for the assembly of active protein kinases.
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14377-82. doi: 10.1073/pnas.0807988105. Epub 2008 Sep 11.
8
Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery.
J Med Chem. 2008 Sep 11;51(17):5149-71. doi: 10.1021/jm800475y. Epub 2008 Aug 19.
9
Benzothiazole based inhibitors of p38alpha MAP kinase.
Bioorg Med Chem Lett. 2008 Mar 15;18(6):1874-9. doi: 10.1016/j.bmcl.2008.02.011. Epub 2008 Feb 10.
10
Strong and weak hydrogen bonds in protein-ligand complexes of kinases: a comparative study.
Amino Acids. 2008 May;34(4):617-33. doi: 10.1007/s00726-007-0015-4. Epub 2008 Jan 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验